aminoimidazole carboxamide has been researched along with Mesothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heyer, CL; Moran, RG; Racanelli, AC; Rothbart, SB | 1 |
| Baker, LH; Borden, EC; Creech, RH; Phillips, M; Samson, MK; Wanebo, HJ; Wasser, LP | 1 |
1 trial(s) available for aminoimidazole carboxamide and Mesothelioma
| Article | Year |
|---|---|
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
Topics: Adult; Aged; Aminoimidazole Carboxamide; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Pleural Neoplasms; Random Allocation | 1987 |
1 other study(ies) available for aminoimidazole carboxamide and Mesothelioma
| Article | Year |
|---|---|
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Division; Enzyme Activation; Folic Acid Antagonists; Glutamates; Glycine; Guanine; Humans; Kinetics; Lung Neoplasms; Mesothelioma; Pemetrexed; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinases; Ribonucleotides; TOR Serine-Threonine Kinases | 2009 |